Versatile photoluminescence tuning in carbon dots through heteroatom doping and surface passivation and/or functionalization (SPF).

In this study, we report a novel and efficient fluorescence probe synthesized by Tris(hydroxymethyl)aminomethane-derived carbon dots (CDs)-modified hexagonal cobalt oxyhydroxide(CoOOH) nanoflakes (Tris-derived CDs-CoOOH) for monitoring of cerebral ascorbic acid (AA) in brain microdialysate. The as-prepared Tris-derived CDs with the fluorescence quantum yield of 7.3% are prepared by a one-step pyrolysis strategy of the sole precursor and used as the signal output. After being hybridized with CoOOH nanoflakes to form Tris-derived CDs-CoOOH, the luminescence of the Tris-derived CDs can be efficiently quenched by CoOOH via fluorescence resonance energy transfer (FRET). Due to the specific redox reaction between the enediol group of AA and hexagonal CoOOH nanoflakes, AA can reduce the hexagonal CoOOH nanoflakes in the Tris-derived CDs-CoOOH and lead to collapse of the hybrized structure, then the release of Tris-derived CDs, and thus finally the fluorescence recovery. Moreover, cobalt ions (II), generated by CoOOH nanoflakes oxidizing AA, almost have no obvious interference on the fluorescence probe, i.e., Tris-derived CDs, which could be ascribed to the surface of Tris-derived CDs containing a few strong chelation groups such as amino/carboxyl/thiol groups, instead of plenty of -OH groups with weak chelation with Co(2+). On the basis of this feature, the Tris-derived CDs-CoOOH fluorescent probe demonstrates a linear range from 100 nM to 20 μM with the detection limit of ∼50 nM, i.e., with an improved sensitivity toward AA detection. Compared with other turn-on fluorescent methods using convenient fluorophore-nitroxide fluorescent probes for detection of AA, the method demonstrated here possesses a facial synthesis route, lower limit of detection, and wider linear range, which validates sensing of AA in the cerebral systems during the calm/ischemia process. This study provides a fluorescence assay for the simple yet facial detection of AA in the cerebral systems and assists in the understanding of the biological processes in the physiological and pathological study.

We report on a single-step thermolysis strategy to prepare highly luminescent nitrogen-doped and amino acidfunctionalized graphene quantum dots (NA-GQDs) by using glycine as both carbon and nitrogen source. The NA-GQDs display an excitation wavelength-dependent fluorescence with maximum excitation and emission wavelengths of 380 and 450 nm, respectively, and a quantum yield of~16 %. Fluorescence is quenched by Fe(III) and Hg(II), and the effect was used to develop a method for the determination of Fe(III). Quenching by Fe(III) is attributed to its higher thermodynamic affinity (compared to other transition-metal ions) for the ligands on the GQDs in which nitrogen atoms mainly act as the chelating atoms. A linear relationship was observed between fluorescence intensity and the concentration of Fe(III) over the 0.5 μM to 0.5 mM range. The detection limit is 0.1 μM.

Herein, we report a series of CuPd catalysts for electrochemical hydrogenation (ECH) of furfural to 2‐methylfuran (MF or FurCH3 where Fur=furyl) in aqueous 0.1 M acetic acid (pH 2.9). The highest faradaic efficiency (FE) for MF reached 75 % at −0.58 V vs. reversible hydrogen electrode with an average partial current density of 4.5 mA cm−2. In situ surface‐enhanced Raman spectroscopic and kinetic isotopic experiments suggested that electrogenerated adsorbed hydrogen (Hads) was involved in the reaction and incorporation of Pd enhanced the surface coverage of Hads and optimized the adsorption pattern of furfural, leading to a higher FE for MF. Density functional theory calculations revealed that Pd incorporation reduced the energy barrier for the hydrogenation of FurCH2* to FurCH3*. Our study demonstrates that catalyst surface structure/composition plays a crucial role in determining the selectivity in ECH and provides a new strategy for designing advanced catalysts for ECH of bio‐derived oxygenates.